Skip to main content
Premium Trial:

Request an Annual Quote

Essen, OriGene Sign Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life sciences tools and services provider Essen Instruments and OriGene will co-develop and co-market ion channel genes for use in gene expression activities in mammalian cell line research, Essen said today.

OriGene, which makes genetics-related products and has a collection of human cDNA clones, will clone and engineer ion channel genes and will optimize methods for the mammalian lines.

Ann Arbor, Mich.-based Essen will use its ion channel analysis technologies, including planar assay electrophysiology and optical imaging, to select and characterize the cell lines.

Kirk Schroeder, Essen's president, said in a statement that developing ion channel gene lines with OriGene's molecular biology capabilities "creates a powerful synergy for expanding our reagent catalogue."

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.